Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

77 results

Stibbe named ‘Belgium Patent Disputes Firm of the Year' by Managing IP

We are delighted to have been named ‘Belgium Patent Disputes Firm of the Year’ for the second year in a row at the annual Managing IP Awards ceremony held on 21 June 2023.

Colour shifting risks: cartel fines for alleged indirect info exchange upheld

National courts upheld the approach by two national competition authorities towards indirect information exchange, lowering the standard of proof for collusion by competitors when receiving competitively sensitive information from a buyer (or supplier).

Keeping up with Belgian patent litigation: Year case law review 2022

Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law.

International Comparative Legal Guide - Patents Law & Regulations - Belgium Chapter

The ICLG to Patents Law & Regulations covers common issues in patent laws and regulations – including enforcement, amendment, licensing, term extension, and prosecution.

Stibbe advises Novy

Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby.

Stibbe wins four awards at the Benchmark Litigation Europe Awards 2021

Our Brussels office is honoured to have won four awards at the annual Benchmark Litigation Europe Awards ceremony last night. These awards celebrate the leading litigators and most impactful disputes across Europe.

Stibbe named ‘Belgian Trademark Contentious Firm of the Year' by Managing IP

We are delighted to have been named 'Belgian Trademark Contentious Firm of the Year' at the annual Managing IP Awards ceremony last night.

Stibbe advises Blackstone

Stibbe assisted Blackstone with the acquisition of Desotec.

Overview of the most important decisions rendered in Belgian patent litigation cases in 2020

Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law. 

Stibbe named ‘Belgium Patent Contentious Firm of the Year' by Managing IP

We are delighted to have been named ‘Belgium Patent Contentious Firm of the Year’ at the annual Managing IP Awards ceremony on 15 June 2022.

Stibbe advises Goed

A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.

Keeping up with Belgian patent litigation: Year case law review 2023

Stibbe's IP team recapped last year's patent case law in Belgium for the IPKat Blog. IPKat regularly publishes on European patent law and is one of the most popular blogs dedicated to IP law.

Stibbe advises Proximus on the sale of its majority stake in Be-Mobile

Stibbe advises Belgian-listed company Proximus on the sale of its majority stake in Be-Mobile to Arrive.

Stibbe represents Geberit

Stibbe represented Geberit, a leading producer of sanitary systems, in unfair competition law procedures, injunction procedures, preliminary procedures, and seizure procedures.

Stibbe advises the Antwerp Port Authority

Stibbe advises the Antwerp Port Authority on its combination with the port of Zeebrugge.

Stibbe advises care chain Goed

Stibbe advised Goed, the network of pharmacies, home care shops and audiology shops of health insurance fund​ CM, on the sale of its hearing centres chain to Audika Belgium.

Stibbe assists Goed

Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma.

Stibbe advises Aedifica on agreement with Cofinimmo to form Europe’s leading healthcare REIT

Stibbe advised Aedifica on its proposed conditional exchange offer to Cofinimmo and the resulting agreement to combine and create Europe’s leading healthcare REIT.

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page
Reset filters
Date
Content type
  • Article (33)
  • Event (1)
  • Inside Stibbe (7)
  • Matter (36)
Expertise
  • (-) EU and Competition Law (52)
  • (-) Intellectual Property (33)
  • Audit Firms and Accountancy (3)
  • Banking and Finance (60)
  • Capital Markets (41)
  • Compliance, Sanctions and Risk (19)
  • Corporate and M&A (132)
  • Corporate Investigations (5)
  • Criminal Law and Enforcement (27)
  • Employment, Benefits and Pensions (36)
  • Energy, Industry and Climate (58)
  • Environment and Planning (86)
  • ESG & Sustainability (22)
  • Financial Regulation (23)
  • Healthcare and Life Sciences (18)
  • Infrastructure and Mobility (48)
  • Insurance (10)
  • Investment Funds (28)
  • Litigation and Arbitration (48)
  • Mass Litigation (1)
  • Privacy and Data Protection (46)
  • Private Equity (32)
  • Procurement Law (34)
  • Public Law (103)
  • Real Estate (113)
  • Restructuring and Insolvency (11)
  • Sports (5)
  • Tax (61)
  • Tech (31)
  • Technology, Media and Telecommunications (86)
  • Unfair Competition and Consumer Protection (96)
Jurisdiction
  • (-) BE Law (77)
  • EU Law (284)
  • LU Law (16)
  • NL Law (353)
Language
  • Dutch (3)
  • English (72)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2026 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information